| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |